Transgendering Youth
The American Academy of Pediatrics claims that “gender-affirming care” is “evidence-based, medically necessary care that improves the health and well-being of transgender youth.”
IN FACT, a 2023 paper about transgenderizing drugs and surgeries in the journal Current Sexual Health Reports documents that:
- “systematic reviews” have found “the risk/benefit ratio of youth gender transition ranges from unknown to unfavorable.”
- “three recent papers examined the studies that underpin the practice of youth gender transition and found the research to be deeply flawed.”
- “results of long-term studies of adult transgender populations failed to demonstrate convincing improvements in mental health, and some studies suggest that there are treatment-associated harms.”
Those findings are corroborated by:
- a 2023 investigation in the British Medical Journal which found that transgendering children with drugs and surgeries is not “evidence-based.”
- a 2025 paper in the Journal of Sexual Medicine which found that “gender-affirming surgery, while beneficial in affirming gender identity, is associated with increased risk of mental health issues….”
- at least 9 studies which have found that puberty blockers given to youth significantly interfere with their bone development.
